Melanoma, Skin cancer
Results
Phase 2
This trial looked at intetumumab (also called CNTO 95), with or without dacarbazine (DTIC), for advanced melanoma skin cancer.
Recruitment start: 1 May 2005
Recruitment end: 1 July 2007
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor M. Gore
Centocor
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 20 Sept 2012
CRUK internal database number: 994
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
